Dyadic International Inc (DYAI) stock
DYAINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$0.32−0.00 (-1.25%)
Close on Nov 17, 2026Market cap $11.51MP/E –Yield –
Dyadic International operating margin
Operating margin is operating income as a percentage of revenue.
Dyadic International's operating margin for the twelve months ending Sep 30, 2026 was -236.7%. For fiscal 2025 it was -232.8%, against -168.8% the year before. The highest annual figure on record is -168.8% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -232.8% | −63.9 |
| FY2024 | Dec 31, 2024 | -168.8% | +115.1 |
| FY2023 | Dec 31, 2023 | -283.9% | +63.0 |
| FY2022 | Dec 31, 2022 | -346.9% | +265.8 |
| FY2021 | Dec 31, 2021 | -612.7% | +13.2 |
| FY2020 | Dec 31, 2020 | -625.9% | −73.7 |
| FY2019 | Dec 31, 2019 | -552.2% | +33.9 |
| FY2018 | Dec 31, 2018 | -586.1% | +353.6 |
| FY2017 | Dec 31, 2017 | -939.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -403.6% | −238.2 |
| Q2 FY2026 | Jun 30, 2026 | -213.7% | −34.9 |
| Q1 FY2026 | Mar 31, 2026 | -171.3% | +337.5 |
| Q4 FY2025 | Dec 31, 2025 | -271.6% | −84.4 |
| Q3 FY2025 | Sep 30, 2025 | -165.3% | −155.0 |
| Q2 FY2025 | Jun 30, 2025 | -178.9% | +350.4 |
| Q1 FY2025 | Mar 31, 2025 | -508.8% | +126.4 |
| Q4 FY2024 | Dec 31, 2024 | -187.2% | +128.7 |
| Q3 FY2024 | Sep 30, 2024 | -10.4% | +422.9 |
| Q2 FY2024 | Jun 30, 2024 | -529.3% | −255.7 |
| Q1 FY2024 | Mar 31, 2024 | -635.2% | −425.6 |
| Q4 FY2023 | Dec 31, 2023 | -315.9% | −14.8 |
| Q3 FY2023 | Sep 30, 2023 | -433.2% | −221.4 |
| Q2 FY2023 | Jun 30, 2023 | -273.6% | +230.2 |
| Q1 FY2023 | Mar 31, 2023 | -209.7% | +213.6 |
| Q4 FY2022 | Dec 31, 2022 | -301.1% | +1044.5 |
| Q3 FY2022 | Sep 30, 2022 | -211.9% | +267.8 |
| Q2 FY2022 | Jun 30, 2022 | -503.8% | −91.2 |
| Q1 FY2022 | Mar 31, 2022 | -423.3% | +297.8 |
| Q4 FY2021 | Dec 31, 2021 | -1345.7% | −689.8 |
| Q3 FY2021 | Sep 30, 2021 | -479.7% | +139.1 |
| Q2 FY2021 | Jun 30, 2021 | -412.7% | +121.0 |
| Q1 FY2021 | Mar 31, 2021 | -721.1% | +34.4 |
| Q4 FY2020 | Dec 31, 2020 | -655.9% | −208.9 |
| Q3 FY2020 | Sep 30, 2020 | -618.8% | −191.2 |
| Q2 FY2020 | Jun 30, 2020 | -533.7% | +224.0 |
| Q1 FY2020 | Mar 31, 2020 | -755.5% | −149.0 |
| Q4 FY2019 | Dec 31, 2019 | -447.0% | −190.0 |
| Q3 FY2019 | Sep 30, 2019 | -427.6% | +249.8 |
| Q2 FY2019 | Jun 30, 2019 | -757.7% | +368.4 |
| Q1 FY2019 | Mar 31, 2019 | -606.5% | +603.2 |
| Q4 FY2018 | Dec 31, 2018 | -257.0% | – |
| Q3 FY2018 | Sep 30, 2018 | -677.3% | – |
| Q2 FY2018 | Jun 30, 2018 | -1126.1% | – |
| Q1 FY2018 | Mar 31, 2018 | -1209.7% | – |
See a number that looks wrong?